Pavion Blue Capital’s Clorox CLX Stock Holding History

Pavion Blue Capital’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$202K	Sell	1,950 -300	-13%	-$34K	0.09%	107
2025 Q4	$227K	Hold	2,250	–	–	0.09%	97
2025 Q3	$277K	Hold	2,250	–	–	0.12%	84
2025 Q2	$270K	Buy	2,250 +300	+15%	+$40K	0.12%	84
2025 Q1	$287K	Hold	1,950	–	–	0.14%	78
2024 Q4	$317K	Hold	1,950	–	–	0.15%	75
2024 Q3	$318K	Sell	1,950 -290	-13%	-$43K	0.15%	76
2024 Q2	$306K	Sell	2,240 -160	-7%	-$22.2K	0.15%	75
2024 Q1	$367K	Hold	2,400	–	–	0.18%	72
2023 Q4	$342K	Hold	2,400	–	–	0.19%	70
2023 Q3	$315K	Hold	2,400	–	–	0.19%	71
2023 Q2	$382K	Hold	2,400	–	–	0.22%	68
2023 Q1	$380K	Hold	2,400	–	–	0.23%	69
2022 Q4	$337K	Hold	2,400	–	–	0.21%	70
2022 Q3	$308K	Sell	2,400 -69	-3%	-$9.96K	0.22%	67
2022 Q2	$348K	Hold	2,469	–	–	0.23%	64
2022 Q1	$343K	Hold	2,469	–	–	0.2%	66
2021 Q4	$430K	Hold	2,469	–	–	0.25%	59
2021 Q3	$409K	Hold	2,469	–	–	0.25%	60
2021 Q2	$444K	Hold	2,469	–	–	0.27%	59
2021 Q1	$476K	Hold	2,469	–	–	0.31%	55
2020 Q4	$499K	Hold	2,469	–	–	0.34%	56
2020 Q3	$519K	Hold	2,469	–	–	0.4%	56
2020 Q2	$542K	Hold	2,469	–	–	0.47%	50
2020 Q1	$428K	Buy	+2,469	New	+$408K	0.44%	51

Other funds holding CLX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Pavion Blue Capital's CLX Position: Q1 2026 in Review

Pavion Blue Capital reduced its Clorox (CLX) stake by 13% in Q1 2026, selling an estimated $34K and leaving 1,950 shares worth $202K. The position accounts for 0.09% of the portfolio, ranked #107.

Pavion Blue Capital first reported a position in CLX in Q1 2020 and has held it in 25 quarters since. The position peaked at $542K in Q2 2020. 1,082 funds tracked by Wall St. Rank hold CLX as of Q1 2026.

Pavion Blue Capital held 1,950 shares of Clorox worth $202K as of Q1 2026.
Pavion Blue Capital sold 300 Clorox shares in Q1 2026, an estimated $34K.
Clorox made up 0.09% of Pavion Blue Capital's portfolio in Q1 2026, its #107 holding.
Pavion Blue Capital first reported a position in Clorox in Q1 2020 and has held it in 25 quarters since.
Pavion Blue Capital's Clorox position peaked at $542K in Q2 2020.
1,082 funds tracked by Wall St. Rank held Clorox as of Q1 2026.

Based on Pavion Blue Capital's 13F filing for Q1 2026, filed 6 May 2026.